Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-000097

Chief Operating Officer gave up 721 shares (to pay taxes)

  • Chief Operating Officer acquired 1,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-31 Exercise or conversion : show line 1 in the form +1,790 41,659 D
2024-12-31 Shares withheld for taxes : show line 2 in the form −721 $22.00 $15,862 40,938 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-31 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,790 11,074 D
Loading xslF345X05/rdgdoc.xml…